Fourth vax available soon in Manitoba
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.95 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.99/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19.95 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 15/11/2021 (1578 days ago), so information in it may no longer be current.
A fourth COVID-19 vaccine has arrived in Manitoba and will be available soon, according to the province’s health minister.
The Janssen vaccine, created by Johnson & Johnson, will reach some pharmacies and medical clinics this week, Minister Audrey Gordon said on Twitter Saturday.
Last week, the province announced an incoming 2,250 dose shipment of the single-shot formula. The Janssen is a viral vector vaccine — the second to be approved in Canada, after AstraZeneca — and is available to people 18 years and older.
“While a second dose of an mRNA vaccine is recommended, Manitobans are considered fully immunized 14 days after a single dose of the Janssen vaccine,” Gordon tweeted Nov. 10.
Canada currently approves two mRNA COVID-19 vaccines, Pfizer and Moderna. Health Canada green lit the Janssen shots last March.
Between now and then, Ottawa was “doing some detailed work with the provinces and territories” to determine whether they’d use Janssen vaccines, Dr. Theresa Tam, Canada’s chief public health officer, told reporters in June.
As of Friday, 2,114,754 COVID-19 shots had been administered in Manitoba. Eighty-seven per cent of eligible Manitobans had at least one dose, while 84.2 per cent had both.
More than 1.5 million jabs contained Pfizer, according to a provincial bulletin posted Wednesday. Another 808,902 were Moderna, while 91,960 came from AstraZeneca.
Manitoba’s online vaccination finder map will be updated once the Janssen vaccine is available, Gordon said.
Clinical trials found a 66 per cent effectiveness rate in protecting against COVID-19, with people who’d received a Janssen dose two weeks earlier, according to the Canadian government’s website.
The U.S. Food and Drug Administration issued emergency use authorization for the Janssen vaccine last February. On Oct. 20, it authorized single booster doses for those who’d gotten the viral vector shot. Americans can mix vaccines if the first dose is Janssen.
gabrielle.piche@winnipegfreepress.com
Gabrielle Piché reports on business for the Free Press. She interned at the Free Press and worked for its sister outlet, Canstar Community News, before entering the business beat in 2021. Read more about Gabrielle.
Every piece of reporting Gabrielle produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press‘s tradition, since 1872, of producing reliable independent journalism. Read more about Free Press’s history and mandate, and learn how our newsroom operates.
Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber.
Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
Gabrielle Piché reports on business for the Free Press. She interned at the Free Press and worked for its sister outlet, Canstar Community News, before entering the business beat in 2021. Read more about Gabrielle.
Every piece of reporting Gabrielle produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press‘s tradition, since 1872, of producing reliable independent journalism. Read more about Free Press’s history and mandate, and learn how our newsroom operates.
Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber.
Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.
Advertisement Advertise With Us